Synovis Life Technologies, Inc. (Nasdaq: SYNO) today announced that its board of directors has approved a program for the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE